newest glp 1 medication Comparing Ozempic, Wegovy and Other GLP-1 Drugs Novo's Wegovy becomes first GLP-1

Clinical research has shown substantial weight loss over time with retatrutide when doses are gradually increased and maintained

This multi-system approach explains why GLP-1 before and after results look so different from traditional diet results

This approach common to GLP-1 and related receptor agonist therapies is designed to minimise gastrointestinal side effects such as nausea, vomiting, and diarrhoea, which are among the most frequently reported adverse events with this class of medication

Understanding the side effect profiles of related peptides provides additional context for what to watch for with GLP-1 class compounds